—

GlaxoSmithKline PLC ADR (GSK) — the peer cohort

As of 2026-11-02 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

GlaxoSmithKline PLC ADR ranks 11 of 11 in its cohort on the Closelooknet composite (54/100) — the cohort is led by Halozyme Therapeutics Inc at 73/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GSK GlaxoSmithKline PLC ADR 54 45 79 55 info 18.3%
LLY Eli Lilly and Company 65 90 91 24 bull 2.2%
ORNAV.HE Orion Oyj A 62 92 84 29 ok 0.7%
ORNBV.HE Orion Oyj B 62 91 84 29 ok 0.5%
SAN.PA Sanofi SA 59 65 70 59 bull 7.6%
AMGN Amgen Inc 56 91 84 35 watch 2%
NVO Novo Nordisk A/S 56 31 86 75 bear 35.4%
HALO Halozyme Therapeutics Inc 73 97 94 38 ok 3.8%
DXCM DexCom Inc 66 78 80 38 watch 11.1%
ONC BeiGene, Ltd. 64 83 64 30 info 7%
ARGX argenx NV ADR 63 68 74 29 info 18.4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-02

Quick answers

Who are GlaxoSmithKline PLC ADR's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Eli Lilly and Company (LLY), Orion Oyj A (ORNAV.HE), Orion Oyj B (ORNBV.HE), Sanofi SA (SAN.PA), Amgen Inc (AMGN), Novo Nordisk A/S (NVO), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM) and others, as of 2026-11-02.

How does GSK score against its peers?

GlaxoSmithKline PLC ADR's composite reads 54/100, ranking 11 of 11 in its cohort as of 2026-11-02; the cohort's highest composite is Halozyme Therapeutics Inc at 73/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.